Home Conferences Contact Us Continuing Education Jobs Weekly News Archives Readership Profile

Monthly News Archives Pharmacy Awards Search Site Search Magazine Archives



4 October 2002 News Update


Pharmac and GlaxoSmithKline are still negotiating the funding level of Flixotide, after passing the October 1 deadline. Meanwhile Flixotide remains fully subsidised.

GSK medical director Dr Ian Griffiths says he believes Flixotide is a safer and more effective medicine than Becotide and Becloforte. These inhalers contained CFCs, and are being phased out.

A recent AC Nielsen survey shows 72% pf previous Becotide and Becloforte users have better control of their asthma having switched to Flixotide.

Back to welcome page

Back to news archives


Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here
For the answers to last month's quiz click here.


Click here for entry details for the 2003 Zuellig Pharma/Pharmacy Today Awards and to find out last year's winners. Also view and purchase photos of the 2002 Awards.


For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.


To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.

Consumer Health Information

New Zealand Doctor Online